GlobeNewswire

Chart 3

Chart 3

Comparison of Outcomes at Week 8 in Patients Who Entered on ‘Red’ Medications and Were Switched versus Patients Remaining on ‘Red’ Medications
Myriad Genetics, Inc.
Format

PNG

Source

Myriad Genetics, Inc.

Downloads